Cutaneous or mucosal infections - Biotech, Pharma and Life Science Channel

19:58 EDT 30th September 2014 | BioPortfolio

PubMed Articles [5110 Associated PubMed Articles listed on BioPortfolio]

Reverse genetics system for studying human rhinovirus infections.

Human rhinovirus (HRV) contains a 7.2 kb messenger-sense RNA genome which is the template for reproducing progeny viruses after it enters the cytoplasm of a host cell. Reverse genetics refers to the r...

Molecular genotyping of human rhinovirus by using PCR and sanger sequencing.

Human rhinovirus (HRV) is the virus most often associated with acute upper respiratory tract infections. Advances in molecular detection have shown that HRV is also the major viral cause of asthma exa...

Molecular identification and quantification of human rhinoviruses in respiratory samples.

PCR-based molecular assays have become standard diagnostic procedures for the identification and quantification of human rhinoviruses (HRVs) and other respiratory pathogens in most, if not all, clinic...

A prospective 12-week mucosal healing assessment of small bowel Crohn's disease as detected by capsule endoscopy.

Mucosal healing is increasingly recognized as an important treatment goal in Crohn's disease (CD). Data from colonic disease shows improved long-term outcomes in patients achieving complete mucosal he...

Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries.

There is little information on the incidence of AIDS-defining events which have been reported in the literature to be associated with immune reconstitution inflammatory syndrome (IRIS) after combined ...

Innovation of Novel Antibiotics: An Economic Perspective.

Despite the public attention to antibiotic overuse and the specter of antimicrobial-resistant pathogens, current infections necessitate the use of antibiotics. Yet, patients and providers may not full...

Effects of nitrogen and potassium fertilization on the susceptibility of tomatoes to post-harvest proliferation of Salmonella enterica.

Fresh fruits and vegetables are increasingly recognized as vehicles of salmonellosis. Pre- and post-harvest environmental conditions, and physiological, and genetic factors are thought to contribute t...

Renal Pathology: SC23-2 RENAL TRANSPLANT PATHOLOGY: REVIEW AND UPDATE.

Renal transplant pathology forms an integral part of medical kidney diseases requiring a biopsy for diagnosis, prognosis and/or appropriate therapy. Often, multiple transplant biopsies are performed t...

Pediatric and Perinatal Pathology: SY21-2 PERINATAL LIVER PATHOLOGY.

The pathologist may encounter perinatal liver disease at autopsy, when examining a stillbirth or neonatal death, or on liver biopsy to investigate the cause of neonatal jaundice or liver failure. This...

Pediatric and Perinatal Pathology: SY21-2 INVASIVE PULMONARY ASPERGILLOSIS IN A PREMATURE NEONATE.

The incidence of opportunistic invasive infections has risen dramatically in the last years and morbidity and mortality remains high. Invasive aspergillosis has been described in immunocompromised pat...

News Articles [1998 Associated News Articles listed on BioPortfolio]

Autoimmunity: Impaired mucosal immunity in patients with SLE

J&J buying Alios for $1.75B

Johnson & Johnson is buying the biopharmaceutical company Alios BioPharma Inc. for about $1.75 billion. Alios is a privately held company that focuses on developing therapies for viral diseases. T...

Johnson & Johnson to buy private drug developer for $1.75 bln

Sept 30 (Reuters) - Johnson & Johnson said it would buy privately held drug developer Alios BioPharma Inc for $1.75 billion in cash, to access a portfolio of drugs targeting viral infections.

Mymetics' innovative HIV vaccine candidate to enter new preclinical trial

Mymetics Corporation, a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases across mucosal membranes, announced today that its innov...

Cubist to Present New Data on Antibiotics Portfolio at IDWeek 2014

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will present new data from its antibiotics portfolio at IDWeek 2014, October 8-12, in Philadelphia, PA. ...

Amwell™ with Apple HealthKit™ brings Healthcare to Chronic Patients

BOSTON, Mass., Sept. 30, 2014 /PRNewswire/ -- Until now, telehealth has been largely confined to urgent care conditions such as flu, pink eye, and sinus infections; the longitudinal health data needed...

Mymetics' HIV vaccine candidate gets funding to begin study at Texas Biomedical Research Institute

Mymetics a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases across mucosal membranes, has announced that its innovative HIV vacci...

Mucosis Presents Infectious Diseases Vaccines Pipeline Update at SACHs Associates 14th Annual Biotech in Europe Forum

Mucosis B.V., a clinical stage biotechnology company developing novel vaccines for infectious diseases, will present updates on its research and development program at the Biotech...

Mymetics' Promising HIV Vaccine Candidate Obtains Funding to Begin Study at Texas Biomedical Research Institute

Mymetics Corporation and Texas Biomedical Research Institute / Mymetics' Promising HIV Vaccine Candidate Obtains Funding to Begin Study at Texas Biomedical Research Institute . Processed and tr...

Study Says Deadly Diarrhea Rates Nearly Doubled in a Decade

Infections with the intestinal superbug C. difficile nearly doubled from 2001 to 2010 in U.S. hospitals without noticeable improvement in patient mortality rates or hospital lengths of stay, according...

Events [0 Results]

None

Companies [85 Associated Companies listed on BioPortfolio]

Cell Medica Limited

Cell Medica is a cellular therapeutics company engaged in the development, manufacturing and marketing of T cell immunotherapy approaches for the treatment of infections and cance...

Global Virus Network (GVN)

The Global Virus Network (GVN) is an independent, not for profit organization, comprised of leading medical virologists from Argentina, Australia, Belgium, Canada, China, France, ...

Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc. is a privately held biopharmaceutical company focused on applying a novel, small molecule immunotherapy platform to treat severe fungal infections in imm...

Meridian Bioscience Inc.

Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and re...

StableLab

StableLab’s equine blood test detects and measures Serum Amyloid A (SAA), a major acute phase protein, delivering lab-accurate results at the horse’s side, enabli...

virtuwell

virtuwell is a 24/7 online clinic developed by HealthPartners, the largest consumer-governed nonprofit health care organization in the nation with a mission to improve health and ...

Stemedica Cell Technologies Inc.

Stemedica Cell Technologies Inc. is a specialty biopharmaceutical company that is committed to the manufacturing and development of best-in-class, allogeneic, adult stem cells and...

Ario Pharma Ltd

ario pharma ltd focusses on the development of drugs for the treatment of respiratory indications. Ario is about to evaluate the anti-tussive properties of XEN-D0501, a potential best-in-class TRPV1...

TNI BioTech, Inc.

TNI BioTech, Inc. is a biotech company working to combat chronic, life-threatening diseases through the activation and modulation of the body's immune system using our patented im...

Osprey Medical Inc.

Osprey Medical's core technologies originated from research conducted by Dr David Kaye at Melbourne’s Baker IDI Heart and Diabetes Institute. Osprey is focused on improving p...

Clinical Trials [1557 Associated Clinical Trials listed on BioPortfolio]

Experimental AD4-H5-VTN Vaccine in Healthy Volunteers

This is a Phase 1 randomized, single center, dose-escalation study designed to evaluate the safety and immunogenicity of live, replication competent recombinant Adenovirus type 4-H5N1Influ...

EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection

Background: - HIV-infected patients have a weakened immune system, and chemotherapy, which is used to treat lymphoma, probably causes further damage to the immune system. ...

Safety Study of Maraviroc's Effect on Human Osteoclasts

This study is to investigate the safety of maraviroc by examining whether there is bone metabolism dysfunction in actual use of maraviroc in human body, or not, measuring bone mineral dens...

RSV F Dose-Ranging Study in Women

The purpose of this study is to evaluate the immunogenicity and safety of multiple formulations of an RSV-F protein nanoparticle vaccine, with aluminum, in healthy women of child-bearing a...

Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma

This phase I trial studies the side effects and best dose of silicon phthalocyanine 4 and photodynamic therapy in treating patients with stage IA-IIA cutaneous T-cell non-Hodgkin lymphoma....

TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Children and Adolescents

The primary objective is to continue the provision of etravirine (ETR) for patients who previously received ETR in a clinical pediatric trial sponsored by or in collaboration with Tibotec,...

Microbiology & Immunology of the Chronically-inflamed Airway

Chronic obstructive pulmonary disease (COPD) is the fourth most common cause of death and the only one of the common causes that is still rising. The main effects of the disease are the de...

Comparison of Immune Response in Normal Volunteers and Patients With Helminth Infections

This study will compare the structure, chemical composition and other characteristics of skin and blood in people with and without parasitic infections. Cell samples will be taken from bl...

Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis

The objective of this Surveillance is to verify the following subject matters concerning Tofacitinib (Xeljanz) under general practice. 1) Occurrence of adverse reactions, factors that ...

A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

This 3 arm study will compare the efficacy and safety of beta-lactam with that o f 'standard care' in patients with complicated skin and skin structure infection s requiring hospitalizatio...

Medical and Biotech [MESH] Definitions

A genus of DNA viruses in the family PAPILLOMAVIRIDAE, causing cutaneous or mucosal papillomas in cattle.

A genus of DNA viruses in the family PAPILLOMAVIRIDAE, causing cutaneous and mucosal lesions in rabbits. COTTONTAIL RABBIT PAPILLOMAVIRUS is the type species.

A genus of DNA viruses in the family papillomaviridae, causing mucosal and cutaneous lesions in cats and dogs. Canine oral papillomavirus is the type species.

A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals including rodents. The Leishmania mexicana complex causes both cutaneous (LEISHMANIASIS, CUTANEOUS) and diffuse cutaneous leishmaniasis (LEISHMANIASIS, DIFFUSE CUTANEOUS) and includes the subspecies amazonensis, garnhami, mexicana, pifanoi, and venezuelensis. L. m. mexicana causes chiclero ulcer, a form of cutaneous leishmaniasis (LEISHMANIASIS, CUTANEOUS) in the New World. The sandfly, Lutzomyia, appears to be the vector.

Drugs that act locally on cutaneous or mucosal surfaces to produce inflammation; those that cause redness due to hyperemia are rubefacients; those that raise blisters are vesicants and those that penetrate sebaceous glands and cause abscesses are pustulants; tear gases and mustard gases are also irritants.

Search BioPortfolio:
Loading
Advertisement
Advertisement
review and buy Cutaneous or mucosal infections market research data and corporate reports here

Channels Quicklinks